The Journal of Immunology · 1999 · 171 citations · 40 references
OocyteGeneticsImmunologyEpigeneticsEmbryologyS100 FamilyNull EmbryosImmunopathologyAdult Bone MarrowKnockout MouseAutoimmunityNull MutationEmbryonic DevelopmentGene ExpressionCell BiologyInborn Error Of ImmunityMouse EmbryoDevelopmental BiologyImmune Cell DevelopmentMedicineCell Development
S100A8 (also known as CP10 or MRP8) was the first member of the S100 family of calcium-binding proteins shown to be chemotactic for myeloid cells. The gene is expressed together with its dimerization partner S100A9 during myelopoiesis in the fetal liver and in adult bone marrow as well as in mature granulocytes. In this paper we show that S100A8 mRNA is expressed without S100A9 mRNA between 6.5 and 8. 5 days postcoitum within fetal cells infiltrating the deciduum in the vicinity of the ectoplacental cone. Targeted disruption of the S100A8 gene caused rapid and synchronous embryo resorption by day 9. 5 of development in 100% of homozygous null embryos. Until this point there was no evidence of developmental delay in S100A8-/- embryos and decidualization was normal. The results of PCR genotyping around 7.5-8.5 days postcoitum suggest that the null embryos are infiltrated with maternal cells before overt signs of resorption. This work is the first evidence for nonredundant function of a member of the S100 gene family and implies a role in prevention of maternal rejection of the implanting embryo. The S100A8 null provides a new model for studying fetal-maternal interactions during implantation.
40
Essential role of Mash-2 in extraembryonic development
François Guillemot, András Nagy, Anna B. Auerbach et al. · Nature · 1994 · 606 citations
An innate view of human pregnancy
Gavin Sacks, Ian L. Sargent, Christopher W.G. Redman · Immunology Today · 1999 · 421 citations